Online citations, reference lists, and bibliographies.
← Back to Search

Efficacy And Tolerability Of Once-weekly Administration Of 17.5 mg Risedronate In Japanese Patients With Involutional Osteoporosis: A Comparison With 2.5-mg Once-daily Dosage Regimen

Hideaki Kishimoto, Masao Fukunaga, Kazuhiro Kushida, Masataka Shiraki, Akira Itabashi, Hajime Nawata, Toshitaka Nakamura, Hiroaki Ohta, Kunio Takaoka, Yasuo Ohashi

Cite This
Download PDF
Analyze on Scholarcy
Share